← Eichor
Study identifier: NCT03497637 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Comparison of Vessel-FFR Versus FFR in Intermediate Coronary Stenoses

Condition: Coronary Artery Disease · Coronary Artery Stenoses  ·  Sponsor: Helios Health Institute GmbH

PhaseNA
Planned participants1054
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This is a prospective, randomized, controlled, multicenter, open-label study designed to assess whether vFFR is non-inferior to FFR in assessment of intermediate coronary stenosis in terms of the occurrence of MACE during 12 months after randomization.

This description comes directly from the study's public registry record.

Talk to the study team

Holger Thiele, MD  ·  +49 341 865 1428  ·  holger.thiele@medizin.uni-leipzig.de

Always discuss trial participation with your own doctor first.

Locations (8)

Heart Center Dresden - University ClinicDresden, GermanyRecruiting
University Clinic ErlangenErlangen, GermanyRecruiting
Universitätsklinikum EssenEssen, GermanyRecruiting
University Clinic Giessen and MarburgGiessen, GermanyRecruiting
Herzzentrum LeipzigLeipzig, GermanyRecruiting
University Clinic LeipzigLeipzig, GermanyRecruiting
Klinikum der Stadt LudwigshafenLudwigshafen, GermanyRecruiting
Lukaskrankenhaus NeussNeuss, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03497637